Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Fertility and Sterility|June 1, 1984
Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisA Lemay, R Maheux, N Faure, et al.
Allergie Et Immunologie|March 14, 2001
[The role of the pharmacist in the educational charge of the asthmatic patient]L Courdent, A Sonneville, G Narcisse, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Mutation R96W in cytochrome P450c17 gene causes combined 17 alpha-hydroxylase/17-20-lyase deficiency in two French Canadian patientsN Laflamme, J F Leblanc, J Mailloux, et al.
Molecular Ecology|November 3, 2005
Parallels in the evolution of the two largest New and Old World seed-beetle genera (Coleoptera, Bruchidae)G J Kergoat, N Alvarez, M Hossaert-McKey, et al.
Canadian Medical Association Journal|September 3, 1977
Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjectsN Faure, J H Dussault, A Nadeau, et al.
Optics Express|May 4, 2016
Ultrafast laser spatial beam shaping based on Zernike polynomials for surface processingJ Houzet, N Faure, M Larochette, et al.
Urology|March 1, 1986
Objective response and disease outcome in 59 patients with stage D2 prostatic cancer treated with either Buserelin or orchiectomy. Disease aggressivity and its association with response and outcomeM Koutsilieris, N Faure, G Tolis, et al.
Fertility and Sterility|May 1, 1983
Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phaseA Lemay, A E Metha, G Tolis, et al.
Fertility and Sterility|March 1, 1982
Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult menN Faure, F Labrie, A Lemay, et al.
Journal of Steroid Biochemistry|July 1, 1983
Suppression of testicular steroidogenesis by the GnRH agonistic analogue Buserelin (HOE-766) in patients with prostatic cancer: studies in relation to dose and route of administrationG Tolis, N Faure, M Koutsilieris, et al.
Pageof 6